BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kheddo P, Golovanov AP, Mellody KT, Uddin S, van der Walle CF, Dearman RJ. The effects of arginine glutamate, a promising excipient for protein formulation, on cell viability: Comparisons with NaCl. Toxicol In Vitro 2016;33:88-98. [PMID: 26873863 DOI: 10.1016/j.tiv.2016.02.002] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Gosselin EA, Noshin M, Black SK, Jewell CM. Impact of Excipients on Stability of Polymer Microparticles for Autoimmune Therapy. Front Bioeng Biotechnol 2020;8:609577. [PMID: 33644005 DOI: 10.3389/fbioe.2020.609577] [Reference Citation Analysis]
2 Geraldes DC, Beraldo-de-araújo VL, Pardo BOP, Pessoa Junior A, Stephano MA, de Oliveira-nascimento L. Protein drug delivery: current dosage form profile and formulation strategies. Journal of Drug Targeting 2020;28:339-55. [DOI: 10.1080/1061186x.2019.1669043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 3.7] [Reference Citation Analysis]
3 Meingast C, Heldt CL. Arginine‐enveloped virus inactivation and potential mechanisms. Biotechnol Progress 2020;36. [DOI: 10.1002/btpr.2931] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Shah M. Commentary: New perspectives on protein aggregation during Biopharmaceutical development. International Journal of Pharmaceutics 2018;552:1-6. [DOI: 10.1016/j.ijpharm.2018.09.049] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Kheddo P, Bramham JE, Dearman RJ, Uddin S, van der Walle CF, Golovanov AP. Investigating Liquid–Liquid Phase Separation of a Monoclonal Antibody Using Solution-State NMR Spectroscopy: Effect of Arg·Glu and Arg·HCl. Mol Pharmaceutics 2017;14:2852-60. [DOI: 10.1021/acs.molpharmaceut.7b00418] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
6 Sheng T, Luo B, Zhang W, Ge X, Yu J, Zhang Y, Gu Z. Microneedle-Mediated Vaccination: Innovation and Translation. Adv Drug Deliv Rev 2021;179:113919. [PMID: 34375682 DOI: 10.1016/j.addr.2021.113919] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
7 Kheddo P, Cliff MJ, Uddin S, van der Walle CF, Golovanov AP. Characterizing monoclonal antibody formulations in arginine glutamate solutions using 1H NMR spectroscopy. MAbs 2016;8:1245-58. [PMID: 27589351 DOI: 10.1080/19420862.2016.1214786] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
8 Batalha IL, Ke P, Tejeda-Montes E, Uddin S, van der Walle CF, Christie G. Dipicolinic acid as a novel spore-inspired excipient for antibody formulation. Int J Pharm 2017;526:332-8. [PMID: 28495581 DOI: 10.1016/j.ijpharm.2017.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Ke P, Batalha IL, Dobson A, Tejeda-montes E, Ekizoglou S, Christie G, Mccabe J, van der Walle CF. Novel salts of dipicolinic acid as viscosity modifiers for high concentration antibody solutions. International Journal of Pharmaceutics 2018;548:682-8. [DOI: 10.1016/j.ijpharm.2018.07.034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
10 Pandya A, Howard MJ, Zloh M, Dalby PA. An Evaluation of the Potential of NMR Spectroscopy and Computational Modelling Methods to Inform Biopharmaceutical Formulations. Pharmaceutics 2018;10:E165. [PMID: 30248922 DOI: 10.3390/pharmaceutics10040165] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
11 Stärtzel P. Arginine as an Excipient for Protein Freeze-Drying: A Mini Review. Journal of Pharmaceutical Sciences 2018;107:960-7. [DOI: 10.1016/j.xphs.2017.11.015] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 6.5] [Reference Citation Analysis]
12 Wang SS, Yan YS, Ho K. US FDA-approved therapeutic antibodies with high-concentration formulation: summaries and perspectives. Antib Ther 2021;4:262-72. [PMID: 34909579 DOI: 10.1093/abt/tbab027] [Reference Citation Analysis]